At the MAPS 2022 Global Annual Meeting in New Orleans, we sat down with Medical Affairs leaders in attendance to discuss a range of issues important to the function. Now as we prepare for the MAPS 2023 Global Annual Meeting in Nashville, March 26-29 (early bird registration open until December 31!), join us in looking back at these important opinions. Have a topic you’d like covered at the 2023 meeting? Email MAPS Communications/Marketing Director, Garth Sundem, with your suggestions!
Rob Kaper discusses his vision for the future of Medical Affairs
Charlotte Kremer, Bjorn Oddens and Danie du Plessis discuss whether Medical Affairs has truly achieved its position as the third strategic pillar in industry
Lobna Salem discusses building a Medical Affairs department from scratch
John Pracyk and Bill Sigmund discuss the differences in the practice of Medical Affairs between pharma and MedTech
Riad Dirani and Omar Dabbous discuss the emerging importance of Health Economics and Outcomes research (HEOR) in Medical Affairs
Tamas Koncz talks about the evolution and future of the Medical Affairs professional
Jose Borlolla and Augusto Grinspan discuss the practice of Medical Affairs and the emergence of the pharma industry in Latin America
Danie du Plessis describes the new competencies Medical Affairs professionals will need to succeed in a changing industry ecosystem
Monica de Abadal describes the value of Medical Affairs to patients and society
Marija Simin Geertsen describes her changing view on the role of Medical Affairs in patient engagement
Kirk Shepard and Nicole-Selenko-Gebauer discuss the challenges of diversity in Medical Affairs, both in patients and within industry positions
Jaime Blais, Deb Braccia and Karen Jursca discuss what is medical excellence and how do you do it in this Medical Affairs table talk.
https://medicalaffairs.org/wp-content/uploads/2022/04/Monica-de-Abadal-Medical-Affairs-Table-Talk-Episode-07-WordPress-Image-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-12-07 14:59:172023-04-12 12:46:23Medical Affairs Leadership Interviews from the MAPS 2022 Global Annual Meeting
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.
https://medicalaffairs.org/wp-content/uploads/2022/11/Evolving-Field-Medical-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-11-02 10:01:332023-11-13 07:59:39Harnessing Cross-Industry Collaboration to Navigate the Evolving Field Medical Landscape
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
https://medicalaffairs.org/wp-content/uploads/2022/08/Broadening-Role-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-08-31 12:32:002023-11-13 08:12:19The Broadening Role of Medical Affairs
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
https://medicalaffairs.org/wp-content/uploads/2022/06/Future-Medical-Affairs-2030-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-06-13 18:58:022024-07-18 12:12:16THE FUTURE OF MEDICAL AFFAIRS 2030
This paper explores the Medical Affairs-based medical insights function and and identifies basic operational elements required to establish medical insights as a core strategic MA function.
https://medicalaffairs.org/wp-content/uploads/2022/05/Insights-Capabilities-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-05-10 20:23:192024-07-18 12:11:23Building Medical Insights Capabilities in Medical Affairs Organizations
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
https://medicalaffairs.org/wp-content/uploads/2022/05/What-is-Medical-Affairs-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-05-09 17:19:332024-07-18 12:10:47Roles, Skills & Career Opportunities in Medical Affairs: A Primer for Job Seekers and Early-Career Professionals
Medical technologies require equipping health care providers with the theoretical knowledge of best and safest use and also ensuring users’ practical competence. This article by the MAPS MedTech and External Education FAWGs overviews these best practices.
https://medicalaffairs.org/wp-content/uploads/2022/04/External-Ed-MedTech-Elevate-Featured-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-04-19 09:39:392024-04-04 11:48:07An Overview of External Education Structure, Activities and Regulations in the MedTech Industry
In this white paper, MedComms, Field Medical and Insights Focus Area Working Groups (FAWGs) demonstrate the value of and elucidate best practices for an insights-driven collaborative approach to creating an iMC S/P.
https://medicalaffairs.org/wp-content/uploads/2022/04/Insights-iMC-Featured-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-04-13 10:05:172024-07-18 12:10:04An Insights-Driven Approach to Creating and Refining the Integrated Medical Communication Strategy and Plan
This white paper provides Medical Affairs professionals with the background and history of Real-World Evidence, and its applications in the biopharma industry to benefit patients.
https://medicalaffairs.org/wp-content/uploads/2022/03/RWE-Help-MA-Featured-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.pngMedical Affairs2022-03-17 12:33:012024-07-18 12:09:41How Can Real-World Evidence Help Medical Affairs Professionals?
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
